By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

PriCara™ 

1000 U.S. Route 202 South

Raritan  New Jersey  08869  U.S.A.
Phone: 800-526-7736 Fax: n/a


SEARCH JOBS








Company News
PriCara™: Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients With Chronic Low Back Pain 9/27/2010 8:54:54 AM
PriCara™, Ortho-McNeil-Janssen Pharmaceuticals, Inc.: Phase 3 Open-Label Study Comparing Tapentadol Extended Release Tablets to Oxycodone Controlled Release Tablets Published by Pain Practice 7/19/2010 8:21:30 AM
PriCara™'s Data Comparing NUCYNTA(R) (tapentadol) Tablets to Oxycodone Immediate Release Tablets Presented at 2010 American Pain Society 5/7/2010 10:44:50 AM
PriCara™ Tapentadol Data to Be Presented at 2010 American Pain Society Annual Meeting 5/3/2010 12:27:39 PM
PriCara™: NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available for Relief of Moderate to Severe Acute Pain 6/23/2009 9:40:00 AM
PriCara™ Recalls 50 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches 1/2/2009 6:46:02 AM
PriCara™ Release: U.S. Federal Circuit Court of Appeals Rules Patent for ACIPHEX(R) Valid and Enforceable 7/22/2008 7:23:39 AM
PriCara™ Recalls 25 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches 2/12/2008 11:23:48 PM
//-->